Teva Pharmaceutical Industries Limited (TEVA) Q4 FY25 Earnings Call

2026 revenue guidance is $16.4-$16.8 billion and free cash flow guidance is $2.0-$2.4 billion.

Q4 FY25 results, source: company transcript and SEC filings
QuarterQ4 FY25
Call date2026-01-31
Length63 minutes
EPS$0.93
EPS consensus$0.63
Revenue$4.7B

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q2 FY26

All TEVA earnings ยท Back to TEVA overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.